Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer, Meredith Culp, Carl Chiang, Janet O’Neil, Rebecca M. Evans, Patrick J. Harrigan, Brenda L. Plassman, James R. Burke, Jingtao Wu, Michael W. Lutz, Stephen Haneline, Adam J. Schwarz, Lon S. Schneider, Kristine Yaffe, Ann M. Saunders, Emiliangelo Ratti, Dag Aarsland, Oda Ackermann, Joscelyn Agron-Figueroa, Thomas Arnold, Peter Bailey, Clive Ballard, Scott Barton, Christine M. Belden, James H. Bergthold, Wendy Bond, Ronald H. Bradley, Walter Braude, Mark Brody, Richard G. Brown, James R. Burke, Joseph Butchart, Theresa A Campbell, Sandra Carusa, Roger Clarnette, Robert M. Cohen, Peter Connelly, Jacquelynn Copeland, Elizabeth Coulthard, Jill Crusey, Craig Curtis, Virginia De Sanctis, George J. Demakis, Natalie L. Denburg, Mardik Donikyan, Rachelle S. Doody, Aaron Ellenbogen, Debra Fleischman, Agnes Flöel, Concetta Forchetti, Néstor Gálvez-Jiménez, Jerome Goldstein, Felicia C. Goldstein, Kathryn Goozee, Daniel Gruener, Jerry Halsten, Howard Hassman, Elliot Henderson, Heinz-Peter Herbst, Steve Higham, Ronald Hofner, DeRen Huang, Fraser Inglis, Clark W. Johnson, Joseph S. Kass, Gregory D. Kirk, Arne Klostermann, Alex A. Knopman, Anne Koplin, David G. Krefetz, Reto W. Kressig, Rosalyn Lai, Gigi Lefebvre, Gabriel C. Léger, Mark Leibowitz, Allan I. Levey, Thomas Leyhe, Scott Losk, Kara Lyons, J F Martin, Paul J. Massman, C. McWilliam, Silvana Micallef, Lefkos Middleton, Hugh Miller, Jacobo Mintzer, Robert J. Mitchell, Ricky Mofsen, Andreas U. Monsch, Philip Moore, Donna Munic-Miller, Marshall Nash, Judith Neugroschl, Margaret Newson, Rupert Noad, Esteban Olivera, Amanda Olley, Omid Omidvar